Share Price and Basic Stock Data
Last Updated: January 8, 2026, 6:45 am
| PEG Ratio | 3.43 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Coromandel International Ltd, operating in the fertilisers industry, reported a market capitalization of ₹68,327 Cr and a current share price of ₹2,315. The company recorded a substantial increase in sales, rising from ₹19,111 Cr in FY 2022 to ₹29,628 Cr in FY 2023, marking a growth of 55%. However, the revenue has shown variability in the subsequent periods, with a decline to ₹22,058 Cr in FY 2024 before rebounding to ₹24,085 Cr in FY 2025. Quarterly sales figures indicate fluctuations; for instance, sales stood at ₹10,113 Cr in September 2022 but dropped to ₹5,476 Cr in March 2023, only to recover to ₹6,988 Cr by September 2023. This volatility reflects external factors such as market demand and commodity price fluctuations, impacting overall revenue consistency. The trailing twelve months (TTM) sales are reported at ₹28,620 Cr, indicating a relatively stable performance compared to the previous fiscal periods. The company’s operational focus on the fertiliser segment remains critical as it navigates through these revenue fluctuations.
Profitability and Efficiency Metrics
Coromandel International reported a net profit of ₹2,381 Cr, translating to a return on equity (ROE) of 16.9% and return on capital employed (ROCE) of 23.2%. The operating profit margin (OPM) stood at 12%, which reflects a competitive positioning within the sector. Analyzing quarterly performance, the OPM showed an upward trend from 10% in September 2022 to 15% in September 2023, although it dipped to 6% in December 2023. The interest coverage ratio (ICR) of 11.38x indicates strong earnings relative to interest expenses, suggesting robust financial health. However, the variability in quarterly net profit—from ₹741 Cr in September 2022 to ₹246 Cr in March 2023, before recovering to ₹755 Cr in September 2023—highlights potential challenges in maintaining consistent profitability. This inconsistency could stem from fluctuating input costs and market dynamics affecting pricing power.
Balance Sheet Strength and Financial Ratios
The balance sheet of Coromandel International reflects a solid financial foundation, with total assets reported at ₹18,917 Cr and reserves amounting to ₹12,149 Cr. The company’s borrowings stood at ₹1,471 Cr, indicating a low debt level relative to its equity, resulting in a total debt to equity ratio of 0.02. This conservative leverage strategy enhances financial stability and provides flexibility for future growth initiatives. The current ratio is reported at 1.89, suggesting good liquidity to meet short-term obligations. Additionally, the company’s book value per share has increased to ₹376.37, which reinforces shareholder value. The inventory turnover ratio of 5.13 indicates efficient inventory management, while the cash conversion cycle (CCC) of -7 days illustrates effective working capital utilization. Overall, these metrics signal a strong balance sheet, positioning Coromandel well against sector norms.
Shareholding Pattern and Investor Confidence
Coromandel International’s shareholding structure indicates a robust promoter holding of 56.88%, reflecting a commitment to the company’s long-term vision. Foreign institutional investors (FIIs) have increased their stake to 14.45%, while domestic institutional investors (DIIs) hold 15.88%. This growing interest from FIIs, particularly the rise from 7.56% in June 2023 to 14.45% in September 2025, suggests enhanced investor confidence in Coromandel’s strategic direction and operational performance. The total number of shareholders has also increased to 143,977, indicating a broadening of the shareholder base. A notable risk, however, lies in the declining trend of promoter holding, which fell from 57.41% in March 2023 to 56.88% in September 2025. This could raise concerns about potential dilution of control and strategic direction, affecting investor sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Coromandel International faces both opportunities and challenges. The company’s strong fundamentals and operational efficiencies position it favorably for growth in the fertiliser sector, especially as agricultural productivity remains a priority in India. However, risks such as commodity price volatility, regulatory changes, and competition from domestic and international players could impact profitability. The company’s ability to manage these risks while capitalizing on growth opportunities will be crucial. Should commodity prices stabilize, and if the company can maintain its operating margins, there is potential for continued revenue growth. Conversely, unexpected fluctuations in input costs or adverse regulatory changes could pressure margins and profitability. In the long term, Coromandel’s strategic investments and focus on innovation will be key to sustaining its market position and enhancing shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat State Fertilizers & Chemicals Ltd | 7,290 Cr. | 183 | 221/156 | 10.9 | 313 | 2.73 % | 6.18 % | 4.77 % | 2.00 |
| Bharat Agri Fert & Realty Ltd | 151 Cr. | 28.6 | 74.0/26.5 | 9.97 | 0.00 % | 6.14 % | 14.8 % | 1.00 | |
| Basant Agro Tech (India) Ltd | 105 Cr. | 11.6 | 18.7/10.4 | 20.8 | 20.0 | 0.43 % | 6.52 % | 2.36 % | 1.00 |
| Zuari Agro Chemicals Ltd | 1,362 Cr. | 324 | 395/155 | 3.94 | 602 | 0.00 % | 12.7 % | 9.06 % | 10.0 |
| Southern Petrochemicals Industries Corporation Ltd (SPIC) | 1,656 Cr. | 81.3 | 128/66.2 | 8.91 | 63.8 | 2.46 % | 16.9 % | 13.8 % | 10.0 |
| Industry Average | 10,821.62 Cr | 398.42 | 49.88 | 185.72 | 0.95% | 13.03% | 10.58% | 6.96 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,113 | 8,310 | 5,476 | 5,693 | 6,988 | 5,464 | 3,913 | 4,729 | 7,433 | 6,935 | 4,988 | 7,042 | 9,654 |
| Expenses | 9,056 | 7,539 | 5,089 | 4,988 | 5,933 | 5,115 | 3,650 | 4,238 | 6,471 | 6,222 | 4,579 | 6,260 | 8,508 |
| Operating Profit | 1,057 | 771 | 387 | 706 | 1,055 | 349 | 263 | 490 | 962 | 713 | 409 | 782 | 1,147 |
| OPM % | 10% | 9% | 7% | 12% | 15% | 6% | 7% | 10% | 13% | 10% | 8% | 11% | 12% |
| Other Income | 32 | 40 | 47 | 44 | 45 | 59 | 84 | 54 | 65 | 114 | 473 | 84 | 116 |
| Interest | 54 | 57 | 52 | 41 | 46 | 38 | 62 | 57 | 66 | 73 | 66 | 68 | 102 |
| Depreciation | 46 | 47 | 45 | 48 | 54 | 64 | 63 | 65 | 69 | 71 | 85 | 121 | 102 |
| Profit before tax | 989 | 706 | 337 | 661 | 1,000 | 306 | 222 | 422 | 892 | 683 | 731 | 677 | 1,059 |
| Tax % | 25% | 25% | 27% | 25% | 25% | 25% | 26% | 27% | 26% | 26% | 21% | 26% | 25% |
| Net Profit | 741 | 527 | 246 | 494 | 755 | 228 | 164 | 309 | 659 | 508 | 578 | 502 | 793 |
| EPS in Rs | 25.20 | 17.92 | 8.38 | 16.80 | 25.71 | 7.85 | 5.45 | 10.56 | 22.55 | 17.37 | 19.67 | 17.13 | 27.31 |
Last Updated: January 2, 2026, 1:37 am
Below is a detailed analysis of the quarterly data for Coromandel International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 9,654.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,042.00 Cr. (Jun 2025) to 9,654.00 Cr., marking an increase of 2,612.00 Cr..
- For Expenses, as of Sep 2025, the value is 8,508.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,260.00 Cr. (Jun 2025) to 8,508.00 Cr., marking an increase of 2,248.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 1,147.00 Cr.. The value appears strong and on an upward trend. It has increased from 782.00 Cr. (Jun 2025) to 1,147.00 Cr., marking an increase of 365.00 Cr..
- For OPM %, as of Sep 2025, the value is 12.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Jun 2025) to 12.00%, marking an increase of 1.00%.
- For Other Income, as of Sep 2025, the value is 116.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Jun 2025) to 116.00 Cr., marking an increase of 32.00 Cr..
- For Interest, as of Sep 2025, the value is 102.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 68.00 Cr. (Jun 2025) to 102.00 Cr., marking an increase of 34.00 Cr..
- For Depreciation, as of Sep 2025, the value is 102.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 121.00 Cr. (Jun 2025) to 102.00 Cr., marking a decrease of 19.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 1,059.00 Cr.. The value appears strong and on an upward trend. It has increased from 677.00 Cr. (Jun 2025) to 1,059.00 Cr., marking an increase of 382.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Jun 2025) to 25.00%, marking a decrease of 1.00%.
- For Net Profit, as of Sep 2025, the value is 793.00 Cr.. The value appears strong and on an upward trend. It has increased from 502.00 Cr. (Jun 2025) to 793.00 Cr., marking an increase of 291.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 27.31. The value appears strong and on an upward trend. It has increased from 17.13 (Jun 2025) to 27.31, marking an increase of 10.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,053 | 11,306 | 11,481 | 10,031 | 11,083 | 13,225 | 13,137 | 14,182 | 19,111 | 29,628 | 22,058 | 24,085 | 28,620 |
| Expenses | 9,246 | 10,450 | 10,712 | 9,048 | 9,822 | 11,775 | 11,400 | 12,193 | 16,954 | 26,726 | 19,678 | 21,508 | 25,569 |
| Operating Profit | 808 | 856 | 769 | 983 | 1,261 | 1,450 | 1,737 | 1,989 | 2,156 | 2,902 | 2,380 | 2,577 | 3,051 |
| OPM % | 8% | 8% | 7% | 10% | 11% | 11% | 13% | 14% | 11% | 10% | 11% | 11% | 11% |
| Other Income | 46 | 50 | 87 | 54 | 55 | 8 | 35 | 76 | 141 | 171 | 223 | 703 | 787 |
| Interest | 240 | 210 | 221 | 224 | 178 | 251 | 235 | 106 | 75 | 190 | 187 | 262 | 309 |
| Depreciation | 96 | 105 | 106 | 101 | 99 | 114 | 158 | 173 | 173 | 182 | 229 | 290 | 378 |
| Profit before tax | 517 | 592 | 529 | 712 | 1,038 | 1,093 | 1,379 | 1,786 | 2,050 | 2,701 | 2,188 | 2,728 | 3,151 |
| Tax % | 29% | 32% | 32% | 33% | 33% | 34% | 23% | 26% | 25% | 25% | 25% | 25% | |
| Net Profit | 365 | 402 | 357 | 477 | 691 | 720 | 1,065 | 1,329 | 1,528 | 2,013 | 1,641 | 2,055 | 2,381 |
| EPS in Rs | 12.59 | 13.80 | 12.27 | 16.35 | 23.64 | 24.63 | 36.36 | 45.30 | 52.08 | 68.46 | 55.78 | 70.14 | 81.48 |
| Dividend Payout % | 36% | 33% | 33% | 31% | 27% | 26% | 33% | 26% | 23% | 18% | 11% | 21% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.14% | -11.19% | 33.61% | 44.86% | 4.20% | 47.92% | 24.79% | 14.97% | 31.74% | -18.48% | 25.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | -21.33% | 44.81% | 11.25% | -40.67% | 43.72% | -23.13% | -9.82% | 16.77% | -50.22% | 43.71% |
Coromandel International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 8% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 10% |
| 3 Years: | 4% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 25% |
| 3 Years: | 31% |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 23% |
| 3 Years: | 21% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 2:15 am
Balance Sheet
Last Updated: December 10, 2025, 2:33 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 |
| Reserves | 2,253 | 2,173 | 2,605 | 2,862 | 2,867 | 3,329 | 4,288 | 5,121 | 6,329 | 7,878 | 9,390 | 11,058 | 12,149 |
| Borrowings | 1,843 | 2,288 | 2,677 | 2,228 | 2,728 | 2,954 | 2,019 | 385 | 395 | 393 | 492 | 780 | 1,471 |
| Other Liabilities | 3,481 | 3,872 | 3,871 | 3,526 | 4,224 | 4,261 | 3,812 | 3,360 | 4,532 | 5,934 | 5,933 | 7,049 | 11,086 |
| Total Liabilities | 7,605 | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,736 |
| Fixed Assets | 1,734 | 1,380 | 1,320 | 1,328 | 1,327 | 1,309 | 2,032 | 2,015 | 2,092 | 2,200 | 3,112 | 4,139 | 5,574 |
| CWIP | 74 | 46 | 42 | 22 | 48 | 191 | 65 | 90 | 141 | 399 | 235 | 396 | 938 |
| Investments | 342 | 352 | 477 | 388 | 221 | 201 | 211 | 214 | 243 | 287 | 854 | 1,031 | 3,079 |
| Other Assets | 5,455 | 6,583 | 7,343 | 6,907 | 8,252 | 8,873 | 7,840 | 6,576 | 8,809 | 11,348 | 11,644 | 13,351 | 15,144 |
| Total Assets | 7,605 | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,736 |
Below is a detailed analysis of the balance sheet data for Coromandel International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
- For Reserves, as of Sep 2025, the value is 12,149.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,058.00 Cr. (Mar 2025) to 12,149.00 Cr., marking an increase of 1,091.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,471.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 780.00 Cr. (Mar 2025) to 1,471.00 Cr., marking an increase of 691.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 11,086.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,049.00 Cr. (Mar 2025) to 11,086.00 Cr., marking an increase of 4,037.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 24,736.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18,917.00 Cr. (Mar 2025) to 24,736.00 Cr., marking an increase of 5,819.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 5,574.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,139.00 Cr. (Mar 2025) to 5,574.00 Cr., marking an increase of 1,435.00 Cr..
- For CWIP, as of Sep 2025, the value is 938.00 Cr.. The value appears strong and on an upward trend. It has increased from 396.00 Cr. (Mar 2025) to 938.00 Cr., marking an increase of 542.00 Cr..
- For Investments, as of Sep 2025, the value is 3,079.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,031.00 Cr. (Mar 2025) to 3,079.00 Cr., marking an increase of 2,048.00 Cr..
- For Other Assets, as of Sep 2025, the value is 15,144.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,351.00 Cr. (Mar 2025) to 15,144.00 Cr., marking an increase of 1,793.00 Cr..
- For Total Assets, as of Sep 2025, the value is 24,736.00 Cr.. The value appears strong and on an upward trend. It has increased from 18,917.00 Cr. (Mar 2025) to 24,736.00 Cr., marking an increase of 5,819.00 Cr..
Notably, the Reserves (12,149.00 Cr.) exceed the Borrowings (1,471.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 807.00 | 854.00 | 767.00 | 981.00 | -1.00 | -1.00 | -1.00 | -384.00 | -393.00 | -391.00 | -490.00 | -778.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 47 | 52 | 59 | 52 | 50 | 48 | 14 | 5 | 7 | 23 | 19 |
| Inventory Days | 86 | 96 | 98 | 88 | 109 | 127 | 109 | 98 | 94 | 69 | 102 | 98 |
| Days Payable | 132 | 131 | 135 | 150 | 162 | 147 | 135 | 110 | 100 | 83 | 117 | 123 |
| Cash Conversion Cycle | 7 | 12 | 15 | -3 | -2 | 30 | 22 | 2 | -1 | -7 | 8 | -7 |
| Working Capital Days | 4 | 11 | 24 | 40 | 27 | 42 | 65 | 64 | 41 | 37 | 44 | 28 |
| ROCE % | 16% | 19% | 15% | 18% | 23% | 23% | 26% | 32% | 35% | 38% | 26% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Midcap Fund | 5,728,809 | 2.26 | 1364.66 | N/A | N/A | N/A |
| HDFC Mid Cap Fund | 4,413,689 | 1.14 | 1051.38 | 4,272,186 | 2025-12-15 00:12:55 | 3.31% |
| Kotak Large & Midcap Fund | 3,250,001 | 2.58 | 774.18 | N/A | N/A | N/A |
| Axis Midcap Fund | 2,692,866 | 1.99 | 641.47 | 4,652,378 | 2025-12-08 05:46:03 | -42.12% |
| DSP Mid Cap Fund | 2,282,965 | 2.74 | 543.83 | 5,065,035 | 2025-12-08 05:46:03 | -54.93% |
| Sundaram Mid Cap Fund | 1,731,201 | 3.09 | 412.39 | 1,712,601 | 2025-12-15 00:12:55 | 1.09% |
| Kotak Flexicap Fund | 1,500,000 | 0.63 | 357.32 | N/A | N/A | N/A |
| Nippon India Growth Mid Cap Fund | 1,210,830 | 0.69 | 288.43 | N/A | N/A | N/A |
| HSBC Value Fund | 972,513 | 1.59 | 231.66 | N/A | N/A | N/A |
| PGIM India Midcap Fund | 872,543 | 1.8 | 207.85 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 70.23 | 55.81 | 68.51 | 52.09 | 45.34 |
| Diluted EPS (Rs.) | 70.12 | 55.81 | 68.38 | 51.98 | 45.22 |
| Cash EPS (Rs.) | 81.42 | 64.39 | 75.49 | 57.83 | 51.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 376.37 | 320.88 | 268.97 | 216.64 | 175.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 376.37 | 320.88 | 268.97 | 216.64 | 175.55 |
| Revenue From Operations / Share (Rs.) | 817.56 | 749.27 | 1007.75 | 651.14 | 483.37 |
| PBDIT / Share (Rs.) | 101.39 | 89.34 | 105.35 | 78.16 | 70.19 |
| PBIT / Share (Rs.) | 91.54 | 81.57 | 99.16 | 72.28 | 64.29 |
| PBT / Share (Rs.) | 94.40 | 75.24 | 92.70 | 69.71 | 60.69 |
| Net Profit / Share (Rs.) | 71.56 | 56.63 | 69.30 | 51.95 | 45.12 |
| NP After MI And SOA / Share (Rs.) | 70.14 | 55.78 | 68.47 | 52.08 | 45.30 |
| PBDIT Margin (%) | 12.40 | 11.92 | 10.45 | 12.00 | 14.52 |
| PBIT Margin (%) | 11.19 | 10.88 | 9.83 | 11.10 | 13.30 |
| PBT Margin (%) | 11.54 | 10.04 | 9.19 | 10.70 | 12.55 |
| Net Profit Margin (%) | 8.75 | 7.55 | 6.87 | 7.97 | 9.33 |
| NP After MI And SOA Margin (%) | 8.57 | 7.44 | 6.79 | 7.99 | 9.37 |
| Return on Networth / Equity (%) | 18.63 | 17.43 | 25.45 | 24.03 | 25.80 |
| Return on Capital Employeed (%) | 22.59 | 24.04 | 34.79 | 31.11 | 33.71 |
| Return On Assets (%) | 10.91 | 10.35 | 14.14 | 13.54 | 14.94 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 1.39 | 1.47 | 2.32 | 1.90 | 1.48 |
| Current Ratio (X) | 1.89 | 2.07 | 1.75 | 1.87 | 1.98 |
| Quick Ratio (X) | 1.21 | 1.28 | 0.99 | 1.05 | 1.19 |
| Inventory Turnover Ratio (X) | 5.13 | 3.00 | 4.84 | 3.80 | 2.65 |
| Dividend Payout Ratio (NP) (%) | 17.08 | 10.75 | 17.51 | 23.03 | 39.70 |
| Dividend Payout Ratio (CP) (%) | 14.98 | 9.44 | 16.06 | 20.70 | 35.12 |
| Earning Retention Ratio (%) | 82.92 | 89.25 | 82.49 | 76.97 | 60.30 |
| Cash Earning Retention Ratio (%) | 85.02 | 90.56 | 83.94 | 79.30 | 64.88 |
| Interest Coverage Ratio (X) | 11.38 | 14.10 | 16.30 | 30.40 | 19.49 |
| Interest Coverage Ratio (Post Tax) (X) | 7.71 | 9.94 | 11.72 | 21.20 | 13.53 |
| Enterprise Value (Cr.) | 55161.09 | 28896.11 | 24436.79 | 21701.81 | 21993.08 |
| EV / Net Operating Revenue (X) | 2.29 | 1.31 | 0.82 | 1.14 | 1.55 |
| EV / EBITDA (X) | 18.47 | 10.99 | 7.89 | 9.46 | 10.68 |
| MarketCap / Net Operating Revenue (X) | 2.42 | 1.44 | 0.87 | 1.23 | 1.60 |
| Retention Ratios (%) | 82.91 | 89.24 | 82.48 | 76.96 | 60.29 |
| Price / BV (X) | 5.26 | 3.36 | 3.27 | 3.69 | 4.41 |
| Price / Net Operating Revenue (X) | 2.42 | 1.44 | 0.87 | 1.23 | 1.60 |
| EarningsYield | 0.03 | 0.05 | 0.07 | 0.06 | 0.05 |
After reviewing the key financial ratios for Coromandel International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 70.23. This value is within the healthy range. It has increased from 55.81 (Mar 24) to 70.23, marking an increase of 14.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 70.12. This value is within the healthy range. It has increased from 55.81 (Mar 24) to 70.12, marking an increase of 14.31.
- For Cash EPS (Rs.), as of Mar 25, the value is 81.42. This value is within the healthy range. It has increased from 64.39 (Mar 24) to 81.42, marking an increase of 17.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 376.37. It has increased from 320.88 (Mar 24) to 376.37, marking an increase of 55.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 376.37. It has increased from 320.88 (Mar 24) to 376.37, marking an increase of 55.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 817.56. It has increased from 749.27 (Mar 24) to 817.56, marking an increase of 68.29.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 101.39. This value is within the healthy range. It has increased from 89.34 (Mar 24) to 101.39, marking an increase of 12.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.54. This value is within the healthy range. It has increased from 81.57 (Mar 24) to 91.54, marking an increase of 9.97.
- For PBT / Share (Rs.), as of Mar 25, the value is 94.40. This value is within the healthy range. It has increased from 75.24 (Mar 24) to 94.40, marking an increase of 19.16.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 71.56. This value is within the healthy range. It has increased from 56.63 (Mar 24) to 71.56, marking an increase of 14.93.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 70.14. This value is within the healthy range. It has increased from 55.78 (Mar 24) to 70.14, marking an increase of 14.36.
- For PBDIT Margin (%), as of Mar 25, the value is 12.40. This value is within the healthy range. It has increased from 11.92 (Mar 24) to 12.40, marking an increase of 0.48.
- For PBIT Margin (%), as of Mar 25, the value is 11.19. This value is within the healthy range. It has increased from 10.88 (Mar 24) to 11.19, marking an increase of 0.31.
- For PBT Margin (%), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 10.04 (Mar 24) to 11.54, marking an increase of 1.50.
- For Net Profit Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 7.55 (Mar 24) to 8.75, marking an increase of 1.20.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.57. This value is within the healthy range. It has increased from 7.44 (Mar 24) to 8.57, marking an increase of 1.13.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.63. This value is within the healthy range. It has increased from 17.43 (Mar 24) to 18.63, marking an increase of 1.20.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.59. This value is within the healthy range. It has decreased from 24.04 (Mar 24) to 22.59, marking a decrease of 1.45.
- For Return On Assets (%), as of Mar 25, the value is 10.91. This value is within the healthy range. It has increased from 10.35 (Mar 24) to 10.91, marking an increase of 0.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.39. It has decreased from 1.47 (Mar 24) to 1.39, marking a decrease of 0.08.
- For Current Ratio (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.89, marking a decrease of 0.18.
- For Quick Ratio (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.28 (Mar 24) to 1.21, marking a decrease of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.13. This value is within the healthy range. It has increased from 3.00 (Mar 24) to 5.13, marking an increase of 2.13.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 17.08. This value is below the healthy minimum of 20. It has increased from 10.75 (Mar 24) to 17.08, marking an increase of 6.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.98. This value is below the healthy minimum of 20. It has increased from 9.44 (Mar 24) to 14.98, marking an increase of 5.54.
- For Earning Retention Ratio (%), as of Mar 25, the value is 82.92. This value exceeds the healthy maximum of 70. It has decreased from 89.25 (Mar 24) to 82.92, marking a decrease of 6.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.02. This value exceeds the healthy maximum of 70. It has decreased from 90.56 (Mar 24) to 85.02, marking a decrease of 5.54.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 11.38. This value is within the healthy range. It has decreased from 14.10 (Mar 24) to 11.38, marking a decrease of 2.72.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has decreased from 9.94 (Mar 24) to 7.71, marking a decrease of 2.23.
- For Enterprise Value (Cr.), as of Mar 25, the value is 55,161.09. It has increased from 28,896.11 (Mar 24) to 55,161.09, marking an increase of 26,264.98.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 2.29, marking an increase of 0.98.
- For EV / EBITDA (X), as of Mar 25, the value is 18.47. This value exceeds the healthy maximum of 15. It has increased from 10.99 (Mar 24) to 18.47, marking an increase of 7.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 2.42, marking an increase of 0.98.
- For Retention Ratios (%), as of Mar 25, the value is 82.91. This value exceeds the healthy maximum of 70. It has decreased from 89.24 (Mar 24) to 82.91, marking a decrease of 6.33.
- For Price / BV (X), as of Mar 25, the value is 5.26. This value exceeds the healthy maximum of 3. It has increased from 3.36 (Mar 24) to 5.26, marking an increase of 1.90.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 2.42, marking an increase of 0.98.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.03, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Coromandel International Ltd:
- Net Profit Margin: 8.75%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.59% (Industry Average ROCE: 13.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.63% (Industry Average ROE: 10.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 7.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.21
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 32.1 (Industry average Stock P/E: 49.88)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.75%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Fertilisers | Coromandel House, Secunderabad Telangana 500003 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. A Vellayan | Chairman Emeritus |
| Mr. Arun Alagappan | Executive Chairman |
| Mr. Natrajan Srinivasan | Executive Vice Chairman |
| Mr. S Sankarasubramanian | Managing Director & CEO |
| Dr. Raghuram Devarakonda | Executive Director |
| Mr. Arunachalam Vellayan | Whole Time Director |
| Mr. Narayanan Vellayan | Whole Time Director |
| Mr. Sudarshan Venu | Independent Director |
| Dr. Deepali Pant Joshi | Independent Director |
| Mr. Adnan Ahmad | Independent Director |
| Mr. Aditya Himatsingka | Independent Director |
| Mr. Suresh Subramanian | Independent Director |
| Mr. Durgashankar Subramaniam | Independent Director |
FAQ
What is the intrinsic value of Coromandel International Ltd?
Coromandel International Ltd's intrinsic value (as of 08 January 2026) is ₹1801.71 which is 22.27% lower the current market price of ₹2,318.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹68,365 Cr. market cap, FY2025-2026 high/low of ₹2,720/1,590, reserves of ₹12,149 Cr, and liabilities of ₹24,736 Cr.
What is the Market Cap of Coromandel International Ltd?
The Market Cap of Coromandel International Ltd is 68,365 Cr..
What is the current Stock Price of Coromandel International Ltd as on 08 January 2026?
The current stock price of Coromandel International Ltd as on 08 January 2026 is ₹2,318.
What is the High / Low of Coromandel International Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Coromandel International Ltd stocks is ₹2,720/1,590.
What is the Stock P/E of Coromandel International Ltd?
The Stock P/E of Coromandel International Ltd is 32.1.
What is the Book Value of Coromandel International Ltd?
The Book Value of Coromandel International Ltd is 413.
What is the Dividend Yield of Coromandel International Ltd?
The Dividend Yield of Coromandel International Ltd is 0.52 %.
What is the ROCE of Coromandel International Ltd?
The ROCE of Coromandel International Ltd is 23.2 %.
What is the ROE of Coromandel International Ltd?
The ROE of Coromandel International Ltd is 16.9 %.
What is the Face Value of Coromandel International Ltd?
The Face Value of Coromandel International Ltd is 1.00.